NCT03575533 - Bayesian Hemodynamics Model for Personalized Monitoring of Congestive Heart Failure Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

September 1, 2019

Study Completion Date

January 1, 2020

Conditions

Heart Failure

Interventions

DIAGNOSTIC_TEST

Bayesian network 'Sherlock'

Primary objective is to validate the Bayesian Hemodynamics model 'Sherlock'. Criterion for validation is a match between Sherlock's estimate of the Hemodynamic status of a patient and a ground truth based on a cardiologist's judgement.

Trial Locations (1)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden